CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart MRI showdown: which contrast agent wins?
Diagnosis CompletedThis study tested two different contrast agents (Dotarem and Gadovist) used during heart MRI scans to see if they produce equally clear images. 120 adults with coronary artery disease or cardiomyopathy were randomly assigned to receive one of the two agents. The goal was to compa…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Diagnosis
Last updated May 17, 2026 05:05 UTC
-
Heart drug fails to shield duchenne boys from cardiac decline
Prevention CompletedThis study tested whether nebivolol, a beta-blocker, could prevent heart muscle weakness in boys aged 10–15 with Duchenne muscular dystrophy. Participants had normal heart function at the start and were randomly assigned to receive nebivolol or a placebo. The trial found that neb…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated May 11, 2026 20:52 UTC
-
Heart failure mystery solved? Beta-Blockers' secret revealed
Knowledge-focused CompletedThis study looked at how beta-blocker medicines improve heart function in people with heart failure. Researchers measured changes in the heart's ability to contract and pump blood. The goal was to understand the underlying mechanisms, not to test a new treatment. 55 adults with n…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Michael E. DeBakey VA Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:26 UTC
-
Healthy volunteers test heart Drug's absorption under different conditions
Knowledge-focused CompletedThis study looked at how well the body absorbs two different forms of the experimental heart drug HRS-1893, and whether taking it with food changes that. It involved 38 healthy adults aged 18 to 55. The goal was to gather information on drug levels and safety, not to treat any di…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Smartphone ECG + AI could spot hidden heart risks in families
Knowledge-focused CompletedThis study looked at whether a simple mobile ECG device, combined with artificial intelligence, can help find early signs of dilated cardiomyopathy in close relatives of people who have the condition. About 119 adults took part, including patients with the disease and their first…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Scientists probe gene links to inflammation and cancer risk
Knowledge-focused CompletedThis study looked at how small differences in certain genes affect the way blood cells respond to environmental exposures. Researchers collected blood samples from 178 healthy adults aged 18 to 45 to measure gene activity and protein binding. The goal was to better understand why…
Matched conditions: CARDIOMYOPATHY
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC